Integrin α2β1 Targeting DGEA-Modified Liposomal Doxorubicin Enhances Antitumor Efficacy against Breast Cancer

Zhou B., Li M., Xu X., Yang L., Ye M., Chen Y., Peng J., Xiao L., Wang L., Huang S.

Type

Journal article

Journal

Molecular Pharmaceutics

Publisher

ACS Publications

Publication Date

2021

Permalink